Over the past ten years, no shift has fundamentally changed healthcare delivery more than telehealth. Accelerated by the COVID pandemic, the rise of telehealth has allowed providers and patients to develop less formal, more frequent interactions around routine medical services and follow up care. While many providers were forced to adapt to providing remote care, […]
Read articleToday we announced a new, expansive partnership with resurgent professional football league the XFL. The XFL is known for creating unique opportunities to advance the game of football, specifically with the integration of innovative technologies.
Read articleThe XFL and NeuroSync today announced a partnership that establishes NeuroSync’s award-winning EYE-SYNC technology as the Official and Exclusive Concussion Management Technology of the XFL.
Read articleAs the calendar turns on another year, the state of health tech continues on an exciting trajectory. Despite a 2022 that was marred by economic downturn and tech related pullbacks, digital health investments still produced over $15B in funding.
Read articleAs healthcare delivery methods continue to evolve in the post COVID-19 climate, providers are well accustomed to delivering virtual care to their patients. Since the pandemic began and forced clinicians and patients to interact remotely, nearly all providers and most patients in need have experienced care delivery via telemedicine.
Read articleIn 2015, I was first introduced to a military grade prototype of EYE-SYNC. Prior to that, I had read little and heard even less about the clinical utility of eye movement assessments in acute conditions such as concussion. However, when I develop an insatiable curiosity about something novel (and potentially game changing) I become relentless […]
Read articleSyncThink, a next generation neurotechnology company, and makers of the award-winning EYE-SYNC technology, announces today that it will rebrand the company as NeuroSync, as it looks to grow its stance in the neurological health market.
Read articleLast week, we announced a significant milestone in the global mission of our company, one that will allow us to commercialize EYE-SYNC into the 27 countries that make up the European Union (EU).
Read articlePalo Alto, CA and Boston MA – August 10, 2022 – SyncThink, a next generation neurotechnology company, and makers of the award-winning EYE-SYNC technology, announces today that it has completed CE Mark certification, affirming conformity to European Medical Device Regulation (MDR), also known as ISO 13485. EYE-SYNC will be registered as a Class I medical device.
Read articleThis month, we’ll be introducing our newest concussion product feature, the objective convergence measurement. This assessment paradigm features automated measures of both eyes as they follow a target as it moves from distance to the Near Point of Convergence and back to the start position.
Read articleMuch has been written and discussed about the impact that Digital Health is having on the evolution of clinical trials. While many agree that the COVID pandemic has greatly accelerated this process, others are split on the long-term impact Digital Health technologies project to ultimately have on patient outcomes.
Read articleWhile the pandemic is often credited with the accelerated adoption of digital health technologies among healthcare systems, particularly over the past two years, the competition among these organizations remains in its infancy.
Read article